![]() Ventria Bioscience Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. | ![]() Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. | ![]() GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | |
Founding Date | Founding Date 1993 | Founding Date 2011 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Junction City, US HQ Aurora, US | Locations San Diego, US HQ Dublin, IE | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB |
Employees | Employees 244% decrease | Employees 46293% increase | Employees 352106% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 4.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $10.3m (FY, 2025) | Cost of goods $3.3m (FY, 2021) |
Net income | Net income N/A | Net income ($25.5m) (FY, 2025) | Net income ($303.1m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 7.7m | Total funding raised $ 25m | Total funding raised $ 88.7m |

Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View company
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company